相关实验视频

Updated: Jul 19, 2025

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

基于多糖的瘤微环境响应药物输送系统用于癌症治疗

Qimeng Wu¹, Yang Hu², Bing Yu¹

¹College of Chemistry and Chemical Engineering, College of Materials Science and Engineering, Institute of Biomedical Materials and Engineering, Qingdao University, Qingdao 266071, China.

Journal of controlled release : official journal of the Controlled Release Society

|August 14, 2023

概括

基于多糖的药物递送系统 (DDS) 利用独特的瘤微环境 (TME) 指标进行向癌症治疗. 这些智能DDS提供精确的药物释放,推进精确医学策略.

科学领域:

生物材料科学生物材料科学
纳米技术纳米技术
在瘤学瘤学.

背景情况:

瘤微环境 (TME) 生物化学指标为智能药物递送系统 (DDS) 提供了独特的目标.
多糖是DDS建造的理想生物材料,因为它们的生物相容性,生物降解性和独特的特性.

研究的目的:

审查那些对TME生化指标有反应的基于多糖的DDS.
概述这些对TME响应的DDS的分类和设计策略.

主要方法:

基于多糖的DDS的综合文献综述.
对各种DDS格式的分析,包括纳米凝,,纳米复合材料,水凝和微针 (MN).
对TME特定的生物化学指标的评估,用于DDS向.

主要成果:

基于多糖的DDS (纳米凝,小等) 可以被设计为结合TME特定指标.
这些DDS允许精确控制药物输送和释放动力学.
各种基于多糖的DDS设计为向治疗提供了明显的优势.

结论:

基于多糖的对TME敏感的DDS代表了先进癌症治疗的有希望的平台.
这些系统对于开发精准医学方法至关重要.
需要进一步开发,以克服当前的挑战,并充分发挥其治疗潜力.

关键词:

癌症治疗治疗癌症治疗药物输送系统是药物输送系统.聚糖类是一种多糖类.刺激-反应的过程.瘤微环境是一个微环境.

更多相关视频

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Drugs that Stabilize Microtubules

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...